Compounded tirzepatide price index
The 24 compounded tirzepatide programs in our index, from each program's own pricing page, with the basis and read date.
Released: · Last reviewed:
As of November 10, 2026, our compounded tirzepatide price index covers 24 telehealth programs whose lowest all-in monthly figures run from $86 to $280, with a median of $144, using first-party prices read October 15, 2026 and NexLife's prices as of November 6, 2026.
NexLife is fourth-lowest at $115 a month on a 12-month plan. Compounded tirzepatide is not FDA-approved.
Cheapest compounded tirzepatide · November 10, 2026
Cheapest compounded tirzepatide in our index · November 10, 2026: Collective is about $86 a month all-in ($69 plus a $199 yearly membership), WellMedr $89 on a fall sale and Mondae $114 a month on a prepaid 6-month plan. Without those terms, NextMeds ($119), yourEra ($123), Mondae ($126), Eden ($129) and NexLife ($129) print the lowest month-to-month prices.
Market check: 24 programs, $86–$280 a month all-in, median $144 (read October 15, 2026; NexLife November 6, 2026).
The index
| # | Program | Lowest all-in / month | How that figure is reached | Month to month | Same price every dose | Source · read date | Link |
|---|---|---|---|---|---|---|---|
| 1 | Collective | $86 | $69 a month + $199 yearly membership ($16.58/mo) | $69 + membership | Yes | collective.org · October 15, 2026 | Source |
| 2 | WellMedr | $89 | "Starting at" $89 fall-sale price | $89 (sale) | Not stated | wellmedr.com · October 15, 2026 | Source |
| 3 | Mondae | $114 | $114 a month on a prepaid 6-month plan ($684) | $126 | Not stated | mondae.com · October 15, 2026 | Source |
| 4 | NexLife | $115 | $115 a month on a 12-month plan ($1,380 a year) | $129 | Yes | nexlife.us · November 6, 2026 | Source |
| 5 | Embody | $119 | $119 a month on a prepaid 12-month plan ($1,428) | $129 (sale; regular $349) | Not stated | joinem.co · October 15, 2026 | Source |
| 6 | NextMeds | $119 | "from" $119, same price every month; plan term not printed | $119 (from) | Not stated | nextmeds.com · October 15, 2026 | Source |
| 7 | SnagRx | $119 | $119 sale price (was $349) | $119 (sale) | Not stated | snagrx.com · October 15, 2026 | Source |
| 8 | yourEra | $123 | "as low as" $123 | $123 (as low as) | Not stated | yourera.com · October 15, 2026 | Source |
| 9 | CoreAge Rx | $129 | "Starting at" $129, no membership fees | $129 (starting at) | Not stated | coreagerx.com · October 15, 2026 | Source |
| 10 | Eden | $129 | $129 every month, no membership | $129 | Yes | eden.health · October 15, 2026 | Source |
| 11 | GobyMeds | $133 | $399 3-month starter bundle ($133/mo, promo) | $299+ | Not stated | gobymeds.com · October 15, 2026 | Source |
| 12 | Telos RX | $139 | "as low as" $139; price depends on plan length | not printed | Not stated | telosrx.com · October 15, 2026 | Source |
| 13 | Sprout Health | $149 | $149 a month on a 12-month plan ($1,788 up front) | $199 per 4 weeks | Not stated | joinsprouthealth.com · October 15, 2026 | Source |
| 14 | Strut Health | $149 | "as low as" $149 for a 30-day supply on auto-refill | $149 (as low as) | Not stated | struthealth.com · October 15, 2026 | Source |
| 15 | He & She MD | $159 | $159 a month on a 12-month plan | $339 | Not stated | heandshemd.com · October 15, 2026 | Source |
| 16 | Bodybuilding Health+ | $175 | $174.67 a month on a 6-month plan | $209 | Not stated | bbhealthplus.com · October 15, 2026 | Source |
| 17 | IVIM Health | $192 | "starting at" $117 + $75 monthly program fee | $117 + $75 fee | Not stated | ivimhealth.com · October 15, 2026 | Source |
| 18 | Alloy | $199 | "Starting at" $100 + $99 monthly fee | $100 + $99 fee | Not stated | myalloy.com · October 15, 2026 | Source |
| 19 | TelePep | $214 | $214 a month on an annual plan ($2,568 up front) | $249 | Not stated | telepeptide.org · October 15, 2026 | Source |
| 20 | Found | $239 | $239 per 28-day cycle on a 12-month plan | $359 | Not stated | joinfound.com · October 15, 2026 | Source |
| 21 | Pallas Health | $239 | $239 a month average on the annual plan | $299 per 4 weeks | Not stated | pallashealth.co · October 15, 2026 | Source |
| 22 | ShedRx | $239 | "as low as" $239 a month | not printed | Not stated | tryshed.com · October 15, 2026 | Source |
| 23 | MyDrHank | $240 | "From" $240 a month (single read) | $240 (from) | Not stated | mydrhank.com · October 15, 2026 | Source |
| 24 | Enhance.MD | $280 | $280 a month on a 12-month plan (billed every 48 weeks) | $329 | Not stated | enhance.md · October 15, 2026 | Source |
What changed since our July 2026 table
| Program | July 8, 2026 | Now | Change |
|---|---|---|---|
| NexLife | $139 a month (12-month plan); $169 month to month | $115 a month (12-month plan); $129 month to month | Price cut on November 6, 2026 |
| Embody | $129 | $129 sale (regular $349); $119 a month on a $1,428 prepaid year | Now a sale price |
| Henry Meds | $179 | No compounded injectable price printed | Left the index (pending) |
| Sprout Health | $199 | $199 per 4 weeks; $149 a month on a 12-month plan | 12-month plan added |
| Found | $289 | $359 per 28 days month to month; $239 on 12 months | Plan ladder |
| ShedRx | $349 | "as low as" $239 | Lower starting price |
| Eden | Not verified | $129 every month, no membership | Added |
| Mondae | Not tracked | $126 one month; $114 on 6 months prepaid | Added |
| Collective | Not tracked | $69 + $199 yearly membership (about $86) | Added |
Pending: not in the index
Henry Meds printed no compounded injectable tirzepatide price. Mochi Health's weight-loss page printed none; its blog lists per-dose medication prices with a separately billed membership, so it stays pending until its pricing page shows them. Ro, Hims & Hers, Yucca Health and bmiMD blocked automated reads, NewMeMeds did not resolve and SkinnyRx loads prices only in the browser. Earlier figures for these programs are not carried into the index.
Older snapshots
The July 2026 snapshot stays online as a dated page: compounded GLP-1 price index (July 2026) and the June 2026 price report. Machine-readable history: price-history.json.
NexLife
$129 month to month, or $115 a month on a 12-month plan ($1,380 a year), the same price at every dose, with no membership (as of November 6, 2026). Plans of 3 and 6 months are $125 and $119 a month.
Included, per NexLife's plan pages: provider review and medical guidance (NexLife Medical Group), a personalized nutrition plan, a 1:1 call with a wellness coach, 24/7 support and free expedited shipping. The plan pages name three state-licensed 503A pharmacies: Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux's New Drug Store (Lake Charles, LA).
Not the lowest price we track. Compounded tirzepatide is not FDA-approved; a licensed clinician decides whether it is right for you.
See NexLife's current plans → Read the reviewQuestions readers ask
How many programs are in the index?
24 compounded tirzepatide programs with a first-party price we could read on October 15, 2026 (NexLife on November 6, 2026). Programs that print no tirzepatide price, or whose pages could not be read, are listed as pending rather than estimated.
How is the all-in price calculated?
It is the medication price plus any required membership or program fee, with yearly fees divided by 12. Collective's $69 a month plus a $199 yearly membership comes to about $86 a month; IVIM Health's $117 starting price plus a $75 monthly program fee comes to $192. All-in figures let you compare programs with and without memberships.
Is NexLife the cheapest in the index?
No. As of November 6, 2026, NexLife charges $129 month to month and $115 a month on a 12-month plan. In our index, Collective (with its yearly membership), WellMedr (on sale) and Mondae (prepaid 6 months) show lower all-in figures, and Eden matches NexLife's $129 month to month. We rank NexLife first on our full methodology, not on price alone.
Can I download the data?
Yes. The index is published as open data under CC BY 4.0 at /data/tirzepatide-price-index.json and /data/tirzepatide-price-index.csv, with each program's basis, source URL, read date and status. Snapshots are kept in /data/price-history.json.
Is compounded tirzepatide FDA-approved?
No. Compounded tirzepatide is not FDA-approved, and FDA does not review compounded drugs for safety, effectiveness or quality before they are sold. It is made with the drug in Zepbound and Mounjaro, but it is not the same product. Lilly's Zepbound and Mounjaro are the FDA-approved tirzepatide medicines.
Sources
- NexLife, compounded tirzepatide plans, read November 6, 2026.
- Collective, holistic weight loss pricing, read October 15, 2026.
- Mondae, compounded tirzepatide, read October 15, 2026.
- Eden, GLP-1 weight loss pricing, read October 15, 2026.
- Eli Lilly, Zepbound coverage and self-pay savings, read October 15, 2026.
- FDA, Concerns with unapproved GLP-1 drugs used for weight loss, page current as of October 1, 2026.
- Federal Register, 503B bulks list proposal (91 FR 23431), published May 1, 2026.
- FDA warning letter 738238 (Empower Pharmacy), dated September 18, 2026.
Full program list with links: price index and the open dataset tirzepatide-price-index.json (CC BY 4.0).